Home › GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
 

Keywords :   


GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas

2016-01-09 20:38:11| Biotech - Topix.net

's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.

Tags: rating neutral bnp reaffirmed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »